Corrona Psoriasis (PSO) Registry

Trial Profile

Corrona Psoriasis (PSO) Registry

Phase of Trial: Phase IV

Latest Information Update: 20 Feb 2018

At a glance

  • Drugs Adalimumab (Primary) ; Apremilast (Primary) ; Brodalumab (Primary) ; Ciclosporin (Primary) ; Etanercept (Primary) ; Guselkumab (Primary) ; Infliximab (Primary) ; Ixekizumab (Primary) ; Methotrexate (Primary) ; Secukinumab (Primary) ; Ustekinumab (Primary)
  • Indications Psoriasis
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Oct 2017 Results (n=1942, Data cut off October 31, 2016) of cross sectional study published in the Journal of the American Academy of Dermatology
    • 17 Jun 2017 Results assessing patient-reported outcomes in psoriasis patients with concomitant psoriatic arthritis (n=823), presented at the 18th Annual Congress of the European League Against Rheumatism
    • 09 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top